Sift Bio

TenSixty Bio

The company develops an artificial intelligence platform to discover tumor-selective epitopes and create antibody-based therapeutics for healthcare providers and oncology patients.

Siren Bio

This company develops immuno-gene therapies combining viral gene delivery and cytokine immunotherapy to treat solid tumours for cancer patients.

Alceus

This company develops a platform that uses artificial intelligence to design therapeutic proteins and program immune cells for clinicians and researchers treating solid tumours.

Waypoint Bio

This company develops cell therapies for solid tumours using a spatial biology and machine learning platform to assist patients with difficult-to-treat cancers.

Deepflare

Deepflare provides an artificial intelligence platform to predict T-cell immunogenicity for biotechnology and pharmaceutical companies developing vaccines and cancer immunotherapies.

Cytovation

This company develops synthetic peptide immunotherapies to treat patients with solid tumours by targeting cancer cell membranes and stimulating immune responses.

Noetik

This biotechnology company develops precision cancer immunotherapies using machine learning and multimodal human tumour data for pharmaceutical partners and clinical applications.

Alp Bio

This company develops a hybrid platform combining human immune organoids and artificial intelligence to assess immunogenicity risks for biotechnology and pharmaceutical drug developers.